1 month Q3 EPS Estimates for FENC Boosted by Capital One FinancialMarketBeat
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) – Analysts at Capital One Financial lifted their Q3 2024 earnings per share estimates for Fennec Pharmaceuticals in a report issued on Wednesday, October 16th. Capital One Financial analyst N. Q…
Capital One Financial (COF) · Earnings · Nasdaq 100 · Pharmaceuticals
X